Low-grade lymphomas are a non-Hodgkin lymphoma (NHL) subtype. They typically grow more slowly and cause fewer symptoms than NHLs. They still require ongoing monitoring and treatment.
There are two main categories of lymphoma: Hodgkin’s lymphoma and non-Hodgkin’s lymphoma.
Among NHL, doctors group the subtypes into aggressive NHL vs. low-grade NHL. Low-grade lymphomas are a type of NHL cancer that starts in the cells of the lymphatic system. They involve slow-growing cancer cells and have a
This article closely examines low-grade lymphomas, including the different types and available treatments.

Low-grade lymphoma is a type of NHL cancer that starts in the cells of the lymphatic system. The lymphatic system is a network of organs, tissues, and vessels that help fight infections and other diseases.
Low-grade lymphomas are
However, they can still be challenging to treat and may require ongoing monitoring and treatment.
The different types of low-grade NHL include:
Follicular lymphoma
This type of B-cell NHL starts in the follicles of the lymphatic tissue and is the second most common form of NHL, making up almost
Marginal zone lymphoma
This type of NHL affects the marginal zone of the lymph node, a part of the immune system that helps fight infections.
It is more common in older adults, with the average age of diagnosis being 60 years.
Mantle cell lymphoma
This type of B-cell NHL starts in the mantle zone of the lymphatic tissue, which helps produce B cells. It is a low to intermediate-grade NHL and tends to affect older adults, with a median diagnosis age of
Small lymphocytic lymphoma
This is a type of B-cell NHL that affects mature B cells. It is
Lymphoplasmacytic lymphoma
This type of NHL affects plasma cells, a type of immune cell that produces antibodies. It
Skin lymphoma
Cutaneous T-cell lymphoma is a type of T-cell NHL that affects the skin and can cause red or discolored, scaly patches or plaques, itching, and thickening of the skin. It is a slow-growing lymphoma that
The growth and behavior of the cancer cells can change over time, leading to a change in the grade of the lymphoma.
When can low-grade lymphoma turn into high-grade lymphoma?
In
This is why ongoing monitoring and treatment are essential for people with low-grade lymphoma, even if they are in remission. Close monitoring can help detect any changes in the cancer’s progression and ensure appropriate management.
The grade of lymphoma can also affect a person’s outlook and treatment options.
When planning treatment for NHL, doctors consider several factors, including:
- Type and subtype of NHL: The specific type and subtype of NHL
can affect a person’s outlook and treatment options, so it is essential to receive an accurate diagnosis. - Stage of NHL: The stage of the disease, which refers to the extent to which cancer has spread, can affect an individual’s treatment options and outlook.
- Age and overall health: This can affect a person’s available treatment options and ability to tolerate certain treatments.
The main treatments for NHL include:
- Watchful waiting: This involves monitoring the disease without active treatment. Doctors are
more likely to suggest this in cases of low-grade NHLs that are not causing symptoms. - Chemotherapy: This treatment involves intravenous or oral medications to destroy cancer cells.
- Radiation therapy: This treatment involves high-energy beams of radiation that kill cancer cells and shrink tumors.
- Immunotherapy: Medications such as checkpoint inhibitors and monoclonal antibodies enhance the immune system’s ability to fight cancer.
- Stem cell transplant: This procedure involves collecting a person’s stem cells, treating them with high dose chemotherapy or radiation therapy, and returning the stem cells to the body to rebuild the immune system.
- Surgery: Doctors may remove tumors or affected lymph nodes surgically.
Treatment plans may also adjust over time based on the person’s response to therapy and any changes in the disease.
There are many different types of lymphoma, including Hodgkin’s and NHL. NHL can include aggressive and low-grade types.
While many different treatment options are available, it may depend on various factors, including the type of low-grade lymphoma.
Additionally, what starts as a low-grade lymphoma may develop into a higher-grade lymphoma. Therefore, it is important to monitor the progression of the disease.
SOURCES:
- Adult non-Hodgkin lymphoma treatment (PDQ®)–patient version. (2024).
https://www.cancer.gov/types/lymphoma/patient/adult-nhl-treatment-pdq - Jain P, et al. (2019). Mantle cell lymphoma: 2019 update on the diagnosis, pathogenesis, prognostication, and management.
https://onlinelibrary.wiley.com/doi/10.1002/ajh.25487 - Jamil A, et al. (2023). Lymphoma.
https://www.ncbi.nlm.nih.gov/books/NBK560826/ - Kaseb H, et al. (2024). Follicular lymphoma.
https://www.ncbi.nlm.nih.gov/books/NBK538206/ - Kaseb H, et al. (2023). Lymphoplasmacytic lymphoma.
https://www.ncbi.nlm.nih.gov/books/NBK513356/ - Low-grade non-Hodgkin lymphoma. (2021). https://lymphoma-action.org.uk/sites/default/files/media/documents/2022-02/LA_Low-grade%20non-Hodgkin%20lymphoma%20NOV%2021%20DIGITAL.pdf
- Lymphatic system. (n.d.).
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/lymphatic-system - Marginal zone lymphoma. (n.d.). https://lymphoma.org/understanding-lymphoma/aboutlymphoma/nhl/mzl/
- Sapkota S, et al. (2023). Non-Hodgkin lymphoma.
https://www.ncbi.nlm.nih.gov/books/NBK559328/ - Treating non-Hodgkin lymphoma. (n.d.).
https://www.cancer.org/cancer/non-hodgkin-lymphoma/treating.html - Varghese MT, et al. (2022). T-cell lymphoma.
https://www.ncbi.nlm.nih.gov/books/NBK564354/ - Yoshino T, et al. (2020). Differential diagnosis of chronic lymphocytic leukemia/small lymphocytic lymphoma and other indolent lymphomas, including mantle cell lymphoma.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7810253/
